News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Peptomyc Receives Approval for Phase 1b Trial Testing OMO-103 in Combination with Standard of Care for PDAC Patients
Friday, July 28, 2023Peptomyc SL is a specialized biotech company dedicated to developing protein therapeutics for cancer treatment The company has received full approval for its Phase b clinical trial which aims to evaluate the combination of OMO a groundbreaking MYC in...
Hikma Ventures Invests in Octave Bioscience, a Precision Care Platform Focused on Multiple Sclerosis and Other Neurodegenerative Diseases
Thursday, July 27, 2023Hikma Pharmaceuticals PLC Hikma a multinational pharmaceutical company has made a strategic investment through its venture capital arm Hikma Ventures in Octave Bioscience
Pharmabcine Commences Phase I Clinical Trial of Novel TIE2 Agonistic Antibody for NAMD, Administering Initial Patient Dose
Thursday, July 27, 2023PharmAbcine Inc KOSDAQ ks is a clinicalstage biotech company that focuses on developing nextgeneration antibody therapeutics
Myopax's Novel Regenerative Cell Therapy for Exstrophy-Epispadias Complex Granted FDA Orphan Drug Designation
Thursday, July 27, 2023MyoPax a biotechnology company has received Orphan Drug Designation from the US Food and Drug Administration FDA for its advanced regenerative cell therapy aimed at treating ExstrophyEpispadias Complex EEC
Recce Pharmaceuticals Initiates Phase I/II Rapid Infusion Clinical Trial of RECCE® 327 for UTI at Scientia Clinical Research
Thursday, July 27, 2023Reece Pharmaceuticals Ltd ASX RCE FSE RQ has made an exciting announcement regarding the progress of its Phase III clinical trial for a new class of synthetic antiinfectives targeting urinary tract infections UTIs
Newamsterdam Pharma Successfully Completes Patient Enrollment for Pivotal Phase 3 BROADWAY Clinical Trial Studying Obicetrapib in Individuals
Wednesday, July 26, 2023NewAmsterdam Pharma Company NV Nasdaq NAMS has successfully completed patient enrollment for its pivotal Phase BROADWAY clinical trial
EU Approves Jardiance® (Empagliflozin) for the Treatment of Chronic Kidney Disease in Adults
Wednesday, July 26, 2023Boehringer Ingelheim and Eli Lilly jointly announced today that the European Commission EC has granted approval for Jardiance empagliflozin to be used in the treatment of adults with chronic kidney disease CKD
FDA Approves XVIVO's Inclusion of DCD Hearts in IDE Clinical Trial
Wednesday, July 26, 2023XVIVO Perfusion AB STOXVIVOLSERKLFRAXV has received approval from the US Food Drug Administration FDA to include Donation after Circulatory Death DCD hearts in its heart preservation clinical trial known as the PRESERVE Clinical Trial
Nexus Pharmaceuticals, Inc. Receives FDA Approval for Their Pre-Filled Syringe of EMERPHED® (ephedrine sulfate injection)
Tuesday, July 25, 2023Nexus Pharmaceuticals Inc has recently received approval from the US Food and Drug Administration FDA for its latest product EMERPHED ephedrine sulfate injection which comes in two variants of prefilled syringes mgmL and mgmL
Crescendo Biologics Secures $32 Million in Funding and Announces the Expansion of the CB307 Phase 1b Trial in PSMA+ Solid Tumors
Tuesday, July 25, 2023Crescendo Biologics Ltd Crescendo is a clinical stage immunooncology company focused on developing novel targeted T cell enhancing therapeutics Recently the company announced its plans to enhance the ongoing Phase b clinical trial
